Experiences on conversion to once-daily advagraf and sirolimus combination in stable kidney recipients

H. Jun, Cheol Woong Jung, Myung-Gyu Kim, K. T. Park

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In transplant recipients, nephrotoxicity due to long-term use of calcineurin inhibitor (CNI) is a serious problem that cannot be overlooked. Medication compliance can cause graft failure in transplant recipients who are bound to long-term medication. In this study, 36 patients who underwent conversion to once-daily Advagraft and sirolimus combination at Korea University Anam Hospital from September 2011 to March 2013 were retrospectively reviewed at 3 and 6 months for laboratory findings, mean arterial pressure (MAP), and so on. After conversion, serum creatinine level and glomerular filtration rate (GFR) decreased significantly at 3 months (P =.024 and P <.001, respectively). Fasting serum glucose level and proteinuria increased significantly at 6 months (P =.016 and P =.030, respectively). The impact of time after conversion at 3 months was significantly related to the increase in postoperative estimated glomerular filtration rate (eGFR). Graft rejection, morbidity, and mortality did not occur within the study period. A once-daily Advagraf and sirolimus regimen can be a novel standard regimen in stable kidney recipients due to its effects in improving renal function and convenience for patients.

Original languageEnglish
Pages (from-to)400-402
Number of pages3
JournalTransplantation Proceedings
Volume46
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Sirolimus
Glomerular Filtration Rate
Kidney
Medication Adherence
Graft Rejection
Korea
Serum
Proteinuria
Fasting
Creatinine
Arterial Pressure
Morbidity
Transplants
Glucose
Mortality
Transplant Recipients
Calcineurin Inhibitors

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Experiences on conversion to once-daily advagraf and sirolimus combination in stable kidney recipients. / Jun, H.; Jung, Cheol Woong; Kim, Myung-Gyu; Park, K. T.

In: Transplantation Proceedings, Vol. 46, No. 2, 01.01.2014, p. 400-402.

Research output: Contribution to journalArticle

@article{baf980ad70c54ded93852914564f199b,
title = "Experiences on conversion to once-daily advagraf and sirolimus combination in stable kidney recipients",
abstract = "In transplant recipients, nephrotoxicity due to long-term use of calcineurin inhibitor (CNI) is a serious problem that cannot be overlooked. Medication compliance can cause graft failure in transplant recipients who are bound to long-term medication. In this study, 36 patients who underwent conversion to once-daily Advagraft and sirolimus combination at Korea University Anam Hospital from September 2011 to March 2013 were retrospectively reviewed at 3 and 6 months for laboratory findings, mean arterial pressure (MAP), and so on. After conversion, serum creatinine level and glomerular filtration rate (GFR) decreased significantly at 3 months (P =.024 and P <.001, respectively). Fasting serum glucose level and proteinuria increased significantly at 6 months (P =.016 and P =.030, respectively). The impact of time after conversion at 3 months was significantly related to the increase in postoperative estimated glomerular filtration rate (eGFR). Graft rejection, morbidity, and mortality did not occur within the study period. A once-daily Advagraf and sirolimus regimen can be a novel standard regimen in stable kidney recipients due to its effects in improving renal function and convenience for patients.",
author = "H. Jun and Jung, {Cheol Woong} and Myung-Gyu Kim and Park, {K. T.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.transproceed.2014.01.004",
language = "English",
volume = "46",
pages = "400--402",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Experiences on conversion to once-daily advagraf and sirolimus combination in stable kidney recipients

AU - Jun, H.

AU - Jung, Cheol Woong

AU - Kim, Myung-Gyu

AU - Park, K. T.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - In transplant recipients, nephrotoxicity due to long-term use of calcineurin inhibitor (CNI) is a serious problem that cannot be overlooked. Medication compliance can cause graft failure in transplant recipients who are bound to long-term medication. In this study, 36 patients who underwent conversion to once-daily Advagraft and sirolimus combination at Korea University Anam Hospital from September 2011 to March 2013 were retrospectively reviewed at 3 and 6 months for laboratory findings, mean arterial pressure (MAP), and so on. After conversion, serum creatinine level and glomerular filtration rate (GFR) decreased significantly at 3 months (P =.024 and P <.001, respectively). Fasting serum glucose level and proteinuria increased significantly at 6 months (P =.016 and P =.030, respectively). The impact of time after conversion at 3 months was significantly related to the increase in postoperative estimated glomerular filtration rate (eGFR). Graft rejection, morbidity, and mortality did not occur within the study period. A once-daily Advagraf and sirolimus regimen can be a novel standard regimen in stable kidney recipients due to its effects in improving renal function and convenience for patients.

AB - In transplant recipients, nephrotoxicity due to long-term use of calcineurin inhibitor (CNI) is a serious problem that cannot be overlooked. Medication compliance can cause graft failure in transplant recipients who are bound to long-term medication. In this study, 36 patients who underwent conversion to once-daily Advagraft and sirolimus combination at Korea University Anam Hospital from September 2011 to March 2013 were retrospectively reviewed at 3 and 6 months for laboratory findings, mean arterial pressure (MAP), and so on. After conversion, serum creatinine level and glomerular filtration rate (GFR) decreased significantly at 3 months (P =.024 and P <.001, respectively). Fasting serum glucose level and proteinuria increased significantly at 6 months (P =.016 and P =.030, respectively). The impact of time after conversion at 3 months was significantly related to the increase in postoperative estimated glomerular filtration rate (eGFR). Graft rejection, morbidity, and mortality did not occur within the study period. A once-daily Advagraf and sirolimus regimen can be a novel standard regimen in stable kidney recipients due to its effects in improving renal function and convenience for patients.

UR - http://www.scopus.com/inward/record.url?scp=84896444001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896444001&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2014.01.004

DO - 10.1016/j.transproceed.2014.01.004

M3 - Article

C2 - 24655973

AN - SCOPUS:84896444001

VL - 46

SP - 400

EP - 402

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2

ER -